Molecular control of lymphangiogenesis
Identifieur interne : 002600 ( Istex/Checkpoint ); précédent : 002599; suivant : 002601Molecular control of lymphangiogenesis
Auteurs : Megan E. Baldwin [Australie] ; Steven A. Stacker [Australie] ; Marc G. Achen [Australie]Source :
- BioEssays [ 0265-9247 ] ; 2002-11.
Abstract
The lymphatic vasculature plays a critical role in the regulation of body fluid volume and immune function. Extensive research into the molecular mechanisms that control blood vessel growth has led to identification of molecules that also regulate development and growth of the lymphatic vessels. This is generating a great deal of interest in the molecular control of the lymphatics in the context of embryogenesis, lymphatic disorders and tumor metastasis. Studies in animal models carried out over the past three years have shown that the soluble protein growth factors, vascular endothelial growth factor (VEGF)‐C and VEGF‐D, and their cognate receptor tyrosine kinase, VEGF receptor‐3 (VEGFR‐3), are critical regulators of lymphangiogenesis. Furthermore, disfunction of VEGFR‐3 has recently been shown to cause lymphedema. The capacity to induce lymphangiogenesis by manipulation of the VEGF‐C/VEGF‐D/VEGFR‐3 signaling pathway offers new opportunities to understand the function of the lymphatic system and to develop novel treatments for lymphatic disorders. BioEssays 24:1030–1040, 2002. © 2002 Wiley‐Periodicals, Inc.
Url:
DOI: 10.1002/bies.10173
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:8DA607CA4310BE7B13AC87B74EA4F45E859A09E5Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Molecular control of lymphangiogenesis</title><author><name sortKey="Baldwin, Megan E" sort="Baldwin, Megan E" uniqKey="Baldwin M" first="Megan E." last="Baldwin">Megan E. Baldwin</name></author><author><name sortKey="Stacker, Steven A" sort="Stacker, Steven A" uniqKey="Stacker S" first="Steven A." last="Stacker">Steven A. Stacker</name></author><author><name sortKey="Achen, Marc G" sort="Achen, Marc G" uniqKey="Achen M" first="Marc G." last="Achen">Marc G. Achen</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8DA607CA4310BE7B13AC87B74EA4F45E859A09E5</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1002/bies.10173</idno><idno type="url">https://api.istex.fr/document/8DA607CA4310BE7B13AC87B74EA4F45E859A09E5/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004282</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">004282</idno><idno type="wicri:Area/Istex/Curation">004282</idno><idno type="wicri:Area/Istex/Checkpoint">002600</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002600</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Molecular control of lymphangiogenesis</title><author><name sortKey="Baldwin, Megan E" sort="Baldwin, Megan E" uniqKey="Baldwin M" first="Megan E." last="Baldwin">Megan E. Baldwin</name><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>Ludwig Institute for Cancer Research, Royal Melbourne Hospital</wicri:regionArea><wicri:noRegion>Royal Melbourne Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Stacker, Steven A" sort="Stacker, Steven A" uniqKey="Stacker S" first="Steven A." last="Stacker">Steven A. Stacker</name><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>Ludwig Institute for Cancer Research, Royal Melbourne Hospital</wicri:regionArea><wicri:noRegion>Royal Melbourne Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Achen, Marc G" sort="Achen, Marc G" uniqKey="Achen M" first="Marc G." last="Achen">Marc G. Achen</name><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>Ludwig Institute for Cancer Research, Royal Melbourne Hospital</wicri:regionArea><wicri:noRegion>Royal Melbourne Hospital</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>Ludwig Institute for Cancer Research, Post Office Box 2008, Royal Melbourne Hospital, Victoria 3050</wicri:regionArea><wicri:noRegion>Victoria 3050</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">BioEssays</title><title level="j" type="alt">BIOESSAYS</title><idno type="ISSN">0265-9247</idno><idno type="eISSN">1521-1878</idno><imprint><biblScope unit="vol">24</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1030">1030</biblScope><biblScope unit="page" to="1040">1040</biblScope><biblScope unit="page-count">11</biblScope><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>New York</pubPlace><date type="published" when="2002-11">2002-11</date></imprint><idno type="ISSN">0265-9247</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0265-9247</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The lymphatic vasculature plays a critical role in the regulation of body fluid volume and immune function. Extensive research into the molecular mechanisms that control blood vessel growth has led to identification of molecules that also regulate development and growth of the lymphatic vessels. This is generating a great deal of interest in the molecular control of the lymphatics in the context of embryogenesis, lymphatic disorders and tumor metastasis. Studies in animal models carried out over the past three years have shown that the soluble protein growth factors, vascular endothelial growth factor (VEGF)‐C and VEGF‐D, and their cognate receptor tyrosine kinase, VEGF receptor‐3 (VEGFR‐3), are critical regulators of lymphangiogenesis. Furthermore, disfunction of VEGFR‐3 has recently been shown to cause lymphedema. The capacity to induce lymphangiogenesis by manipulation of the VEGF‐C/VEGF‐D/VEGFR‐3 signaling pathway offers new opportunities to understand the function of the lymphatic system and to develop novel treatments for lymphatic disorders. BioEssays 24:1030–1040, 2002. © 2002 Wiley‐Periodicals, Inc.</div></front></TEI><affiliations><list><country><li>Australie</li></country></list><tree><country name="Australie"><noRegion><name sortKey="Baldwin, Megan E" sort="Baldwin, Megan E" uniqKey="Baldwin M" first="Megan E." last="Baldwin">Megan E. Baldwin</name></noRegion><name sortKey="Achen, Marc G" sort="Achen, Marc G" uniqKey="Achen M" first="Marc G." last="Achen">Marc G. Achen</name><name sortKey="Achen, Marc G" sort="Achen, Marc G" uniqKey="Achen M" first="Marc G." last="Achen">Marc G. Achen</name><name sortKey="Stacker, Steven A" sort="Stacker, Steven A" uniqKey="Stacker S" first="Steven A." last="Stacker">Steven A. Stacker</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002600 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 002600 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Checkpoint
|type= RBID
|clé= ISTEX:8DA607CA4310BE7B13AC87B74EA4F45E859A09E5
|texte= Molecular control of lymphangiogenesis
}}
| This area was generated with Dilib version V0.6.31. |  |